3-((E)-2-Pyridin-4-yl-vinyl)-1H-indole

ID: ALA166509

Cas Number: 177181-23-6

PubChem CID: 11775642

Max Phase: Preclinical

Molecular Formula: C15H12N2

Molecular Weight: 220.28

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C(=C/c1c[nH]c2ccccc12)\c1ccncc1

Standard InChI:  InChI=1S/C15H12N2/c1-2-4-15-14(3-1)13(11-17-15)6-5-12-7-9-16-10-8-12/h1-11,17H/b6-5+

Standard InChI Key:  GWFLOYNQTNXGOJ-AATRIKPKSA-N

Molfile:  

     RDKit          2D

 17 19  0  0  0  0  0  0  0  0999 V2000
    0.4917   -2.4375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4917   -1.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9875   -1.7625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7500   -0.3042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2958   -1.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2958   -2.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5542   -0.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3167    2.2208    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8125    0.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0083   -0.9375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8792    1.6083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5167    2.0458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0083   -2.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6250    0.8208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2625    1.2583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7208   -1.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7208   -2.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
  3  1  1  0
  4  2  1  0
  5  6  1  0
  6  1  1  0
  7  4  2  0
  8 12  1  0
  9  7  1  0
 10  5  2  0
 11 14  1  0
 12 15  2  0
 13  6  2  0
 14  9  2  0
 15  9  1  0
 16 17  2  0
 17 13  1  0
  2  5  1  0
 10 16  1  0
 11  8  2  0
M  END

Alternative Forms

Associated Targets(non-human)

Tdo2 Tryptophan 2,3-dioxygenase (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Tdo2 Tryptophan 2,3-dioxygenase (195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 220.28Molecular Weight (Monoisotopic): 220.1000AlogP: 3.73#Rotatable Bonds: 2
Polar Surface Area: 28.68Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.28CX LogP: 3.19CX LogD: 3.19
Aromatic Rings: 3Heavy Atoms: 17QED Weighted: 0.70Np Likeness Score: -0.19

References

1. Madge D, Hazelwood R, Iyer R, Jones H, Salter M.  (1996)  Novel tryptophan dioxygenase inhibitors and combined tryptophan dioxygenase/5-HT reuptake inhibitors,  (7): [10.1016/0960-894X(96)00124-2]
2. Dolusić E, Larrieu P, Moineaux L, Stroobant V, Pilotte L, Colau D, Pochet L, Van den Eynde B, Masereel B, Wouters J, Frédérick R..  (2011)  Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.,  54  (15): [PMID:21726069] [10.1021/jm2006782]

Source